• There will be no cure for type 1 within the next 10 years unless there is an immediate paradigm shift.
  • Major fundraising organizations have objective-based fundraising but not objective-based systems to measure progress toward a cure.
  • The predominant source of funding is from people seeking a cure, but the major non-profits’ efforts are often not aligned with that desire.
  • Adopting a definition of a cure will focus efforts and greatly increase the likelihood of achieving a cure.
  • Unless we demand a cure that is date certain, we will not get a focused response.
  • People’s innate gratitude that there is a charity fighting for a cure has forestalled a healthy demand for accountability.
  • Type 1 and type 2 diabetes are different diseases. Funding should not be co-mingled.
  • A cure will most likely result from overwhelming support for a focused group of initiatives rather than modest support for many.
  • Prevention efforts will not lead to a Practical Cure.
  • Non-profits rely on the message of a type 1 cure to raise funds but allocate a significant portion of donor contributions to activities other than type 1 cure research.